Back to Authors

Arsanjani, Reza

A5126378358 | I4210146710

Mayo Clinic

Mayo Clinic in Florida

Citations 1

Pericardial Effusion and Bruton Tyrosine Kinase Inhibitors in B-Cell Malignant Disease

JAMA Oncology | February 19, 2026 | Volume: 12 | Issue: 4 | Pages: 419

10.1001/jamaoncol.2025.6605 | PMID 41712203

This cohort study examines the association of bruton tyrosine kinase inhibitor therapy in B-cell malignant disease with increased risk of pericardial effusion and cardiovascular outcomes.